002793 罗欣药业
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(162,464)466,888(939,127)120,633(32,750)
投资活动产生之现金流量净额18,363957,426(119,182)(428,422)108,260
筹资活动产生之现金流量净额(97,786)(1,680,908)384,978789,533130,708
汇率变动对现金及现金等价物的影响1,6082,18014,099(1,132)(19,299)
现金及现金等价物净增加/(减少)(240,277)(254,413)(659,232)480,612186,919
期初现金及现金等价物余额579,942834,3551,493,5871,012,974826,055
期末现金及现金等价物余额339,664579,942834,3551,493,5871,012,974